Ron Eastman
InvestorSenior Advisor at Essex Woodlands Healthcare Partners · Director of Technology at Merak Capital
Palo Alto, California, United States
Find your path to Ron
47 people in our graph share verified history with Ron — schools, employers, funds. One of them is your warm intro.
About
Ron Eastman joined Essex Woodlands (EW) in 2006 and was a Managing Director across multiple funds before becoming a Senior Advisor in 2021. He has decades of experience building healthcare businesses, beginning at American Cyanamid Company and later serving as CEO of Geron and leading Rinat Neuroscience, a Genentech spinout acquired by Pfizer in 2006. He holds a B.A. from Williams College and an M.B.A. from Columbia University.
Invests in
BiotechHealthtech
Investments
Led
CoriumElusys TherapeuticsEyePoint PharmaceuticalsProteinSimple
Board seats
Suneva
Per the firm's website.
Colleagues at Essex Woodlands Healthcare Partners
Frequently asked questions
- Who is Ron Eastman?
- Ron Eastman joined Essex Woodlands (EW) in 2006 and was a Managing Director across multiple funds before becoming a Senior Advisor in 2021. He has decades of experience building healthcare businesses, beginning at American Cyanamid Company and later serving as CEO of Geron and leading Rinat Neuroscience, a Genentech spinout acquired by Pfizer in 2006. He holds a B.A. from Williams College and an M.B.A. from Columbia University.
- Where does Ron Eastman work?
- Ron Eastman is Senior Advisor at Essex Woodlands Healthcare Partners.
- What does Ron Eastman invest in?
- Ron Eastman invests in Biotech, Healthtech.
- What boards does Ron Eastman sit on?
- Ron Eastman holds tracked board seats at Suneva.
- What companies has Ron Eastman invested in?
- Investments tracked here include Corium, Elusys Therapeutics, EyePoint Pharmaceuticals, ProteinSimple.
- Does Ron Eastman lead rounds?
- Yes — Ron Eastman has led 4 tracked investments.